Inspire Medical Systems Debt to Equity Ratio 2017-2024 | INSP

Current and historical debt to equity ratio values for Inspire Medical Systems (INSP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Inspire Medical Systems debt/equity for the three months ending September 30, 2024 was 0.00.
Inspire Medical Systems Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.10B $0.70B 0.14
2024-06-30 $0.09B $0.64B 0.14
2024-03-31 $0.10B $0.59B 0.16
2023-12-31 $0.10B $0.57B 0.18
2023-09-30 $0.10B $0.54B 0.18
2023-06-30 $0.09B $0.53B 0.17
2023-03-31 $0.07B $0.51B 0.13
2022-12-31 $0.07B $0.50B 0.14
2022-09-30 $0.06B $0.47B 0.12
2022-06-30 $0.07B $0.23B 0.29
2022-03-31 $0.07B $0.23B 0.29
2021-12-31 $0.07B $0.23B 0.29
2021-09-30 $0.06B $0.22B 0.27
2021-06-30 $0.05B $0.22B 0.24
2021-03-31 $0.05B $0.22B 0.23
2020-12-31 $0.05B $0.23B 0.22
2020-09-30 $0.04B $0.23B 0.19
2020-06-30 $0.04B $0.23B 0.16
2020-03-31 $0.04B $0.13B 0.30
2019-12-31 $0.04B $0.14B 0.30
2019-09-30 $0.04B $0.15B 0.26
2019-06-30 $0.03B $0.15B 0.22
2019-03-31 $0.03B $0.16B 0.20
2018-12-31 $0.04B $0.16B 0.22
2018-09-30 $0.03B $0.10B 0.33
2018-06-30 $0.03B $0.10B 0.31
2018-03-31 $0.03B $-0.01B -6.64
2017-12-31 $0.02B $0.00B 17.91
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.716B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $10.500B 0.00
Hims & Hers Health (HIMS) United States $5.733B 148.28
Axonics (AXNX) United States $3.603B 1762.25
IRhythm Technologies (IRTC) United States $2.729B 0.00
Privia Health (PRVA) United States $2.710B 225.80
Enovis (ENOV) United States $2.621B 17.77
Omnicell (OMCL) United States $2.264B 74.08
Azenta (AZTA) United States $2.250B 112.17
10x Genomics (TXG) United States $1.898B 0.00
Schrodinger (SDGR) United States $1.620B 0.00
Clover Health Investments (CLOV) United States $1.617B 0.00
Phreesia (PHR) United States $1.235B 0.00
Standard BioTools (LAB) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.569B 0.00
Definitive Healthcare (DH) United States $0.528B 91.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.278B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.261B 0.00
TruBridge (TBRG) United States $0.234B 67.96
P3 Health Partners (PIII) United States $0.140B 0.00
American Well (AMWL) United States $0.136B 0.00
EUDA Health Holdings (EUDA) Singapore $0.098B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
111 (YI) China $0.056B 0.00
CareCloud (CCLD) United States $0.051B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00